Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel
Matthew Greenhawt1, Ruchi S Gupta2, J Allen Meadows3
1Section of Allergy and Immunology, Food Challenge and Research Unit, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
Insights
Infant anaphylaxis, often caused by food allergies, presents unique challenges in recognition and treatment for nonverbal infants. Expert guidance is developing to improve diagnosis and management of this emerging risk.
Area of Science:
- Pediatric Allergy and Immunology
- Emergency Medicine
- Neonatal Care
Background:
- Infant anaphylaxis is an increasing concern, primarily triggered by food allergies.
- Recognizing anaphylaxis in infants is difficult due to overlapping symptoms with normal infant behaviors.
- Optimal treatment and diagnosis face real-world challenges in nonverbal infants.
Framework:
- Expert panel convened to establish guiding principles for infant anaphylaxis recognition, diagnosis, and management.
- Developed a framework to guide future infant anaphylaxis guidelines and research initiatives.
- Addressed emergency action planning specifically for infants experiencing anaphylaxis.
Implementation:
- Intramuscular epinephrine remains the primary treatment for infant anaphylaxis.
- FDA-approved epinephrine autoinjectors are now available for infants weighing 7.5-15 kg.
- Healthcare providers need enhanced awareness for improved infant anaphylaxis care.
Implications:
- Future research should focus on validating clinical criteria for infant anaphylaxis diagnosis.
- Identifying risk factors for severe anaphylactic reactions in infants is crucial.
- Improved recognition, diagnosis, and management strategies are needed for infant anaphylaxis.
Abstract:
Infant anaphylaxis is an emerging risk, with food allergy the most common cause. Although the presentation of anaphylaxis involves the same systems as in older children and adults, there are real-world challenges to identifying symptoms of an allergic emergency in nonverbal children, as well as implementing optimal treatment. Recognition of anaphylaxis in infants can be challenging because allergic symptoms and certain normal infant behaviors may overlap. Intramuscular epinephrine is the treatment of choice for infants, as it is for older children and adults, and an epinephrine autoinjector approved by the Food and Drug Administration is now available for infants weighing between 7.5 and 15 kg. A panel of experts sought to develop guiding principles for the recognition, diagnosis, and management of anaphylaxis in infants, and provide a framework for the development of new guidelines and future research. Accordingly, anaphylaxis emergency action planning for infants was addressed by the panel. In considering formation of future infant anaphylaxis guidelines, health care providers should be aware of the needs to improve the recognition, diagnosis, and management of infants with anaphylaxis. Future research should identify and validate clinical criteria for the diagnosis of anaphylaxis in infants, as well as risk factors for the most severe reactions.
Related Concept Videos
Wood Panel Products
The Uncertainty Principle
Hardy-Weinberg Principle
The Pauli Exclusion Principle
The Aufbau Principle and Hund's Rule
Le Chatelier's Principle: Changing Concentration


